Atlas Trials

A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)

Clinical trial NCT01334918 · COMPLETED

Trial details

NCT number
NCT01334918
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Coronary Artery Disease (CAD)
Start date
2011-04-26
Primary completion
2012-07-02
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.